Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2
Julia Velez(Icahn School of Medicine at Mount Sinai), Jian Jin(Icahn School of Medicine at Mount Sinai)
Cited by 36
Related Papers
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
|ACS Chemical Biology|2015|290
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis
|Cancer Discovery|2020|73
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
|Journal of the American Chemical Society|2023|53
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
|Journal of Medicinal Chemistry|2023|50